The Warburg Effect Beyond Cancer: Melatonin as a Metabolic Modulator in Non-Neoplastic Disorders
Abstract
: Aerobic glycolysis, also known as the Warburg effect, and the accumulation of lactate that it causes, are increasingly recognized outside the field of oncology as triggers of chronic non-neoplastic disorders. This review integrates preclinical and clinical evidence to evaluate the ability of melatonin to reverse Warburg-effect-like metabolic reprogramming. Literature on neurodegeneration, age-related sarcopenia, type 2 diabetes, chronic kidney disease, heart failure and pulmonary arterial hypertension (PAH) has been reviewed and synthesised. In all of these conditions, hypoxia-inducible factor 1α (HIF-1α) and pyruvate dehydrogenase kinase 4 (PDK4) inhibit the pyruvate dehydrogenase complex. This diverts pyruvate away from the tricarboxylic acid (TCA) cycle and promotes glycolysis. In cell and animal models, melatonin consistently inhibits PDK4, destabilizes HIF-1α under normoxic conditions, activates SIRT1/3-dependent mitochondrial biogenesis and mitophagy, and eliminates reactive oxygen and nitrogen species. These actions reduce lactate production, restore oxidative phosphorylation and attenuate tissue damage. This appears to induce cognitive and synaptic improvements in Alzheimer’s and Parkinson’s disease models, increased muscle mass and function in ageing rodents, improved insulin sensitivity alongside suppression of hepatic gluconeogenesis in diabetic models, reduced fibrosis in nephropathy,and normalization of vascular remodeling in hypoxia-induced pulmonary arterial…
Read the paper
Related studies
- Tryptophan Metabolism and Gut-Brain Homeostasis
- Rationale for a Multi-Factorial Approach for the Reversal of Cognitive Decline in Alzheimer’s Disease and MCI: A Review
- Prioritized Research for the Prevention, Treatment, and Reversal of Chronic Disease: Recommendations From the Lifestyle Medicine Research Summit
- Relationship between sleep disorders and gut dysbiosis: what affects what?
- The role of CLOCK gene in psychiatric disorders: Evidence from human and animal research
- Genetic, Transcriptome, Proteomic, and Epidemiological Evidence for Blood-Brain Barrier Disruption and Polymicrobial Brain Invasion as Determinant Factors in Alzheimer’s Disease
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.